Combining pre-operative vaccination with peri-operative PDE5 inhibitors has shown promising preclinical results [134] which has prompted us to initiate a Phase 1 study of peri-operative administration of Tadalafil (a PDE5 inhibitor) in combination with influenza in CRC surgery patients (NCT02998736). This evidence concerns the gene PDE5A and influenza.